|
Combination - The Top 50 Pharmaceutical and Biotechnology Companies with Their PipelinesPublished by: PharmaLive Published: May. 1, 2008 - 278 Pages Table of Contents
AbstractPharmaLive and Med Ad News editors present the prescription medicines in development for the world's top 50 pharmaceutical companies and the top 50 biotechnology companies. In these two special reports, the top companies are determined based on their health-care revenue.Each of these special reports features the pipelines presented by company in alphabetical order. The pipelines in these special reports provide the following for each product: chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer. These phases of the pipeline have been considered for these special reports - preclinical development, Phase I, Phase II, Phase III and awaiting approval. Both reports concentrate on products in development in the United States, Europe and Japan. Additionally included in each report is a chart containing the R&D expenditure for the top 50 companies in each category. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||